000			01842 a2200517 4500
005			20250512114010.0
264		0	_c19730608
008			197306s 0 0 rus d
022			_a0003-5637
040			_aNLM _beng _cNLM
100	1		_aErmol'eva, Z V
245	0	0	_a[Prodigiozan and antibiotics]. _h[electronic resource]
260			_bAntibiotiki _cDec 1972
300			_a1109-28 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAntigen-Antibody Reactions _xdrug effects
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBronchitis _xdrug therapy
650	0	4	_aCholecystitis _xdrug therapy
650	0	4	_aColitis _xdrug therapy
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aFemale
650	0	4	_aGenital Diseases, Female _xdrug therapy
650	0	4	_aHepatitis A _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInflammation _xdrug therapy
650	0	4	_aInfluenza, Human _xprevention & control
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aOccupational Diseases _xdrug therapy
650	0	4	_aPeriodontal Diseases _xdrug therapy
650	0	4	_aPhagocytosis _xdrug effects
650	0	4	_aPituitary-Adrenal System _xdrug effects
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications, Infectious _xdrug therapy
650	0	4	_aProdigiosin _xtherapeutic use
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aPyelonephritis _xdrug therapy
650	0	4	_aRadiation-Protective Agents _xtherapeutic use
650	0	4	_aSurgical Wound Infection _xdrug therapy
650	0	4	_aTonsillitis _xdrug therapy
650	0	4	_aVirus Diseases _xdrug therapy
700	1		_aVaĭsberg, G E
773	0		_tAntibiotiki _gvol. 17 _gno. 12 _gp. 1109-28
999			_c4576583 _d4576583